herkisi The sheer size and dominance of the “Magnificent 7” club has been well documented, especially in light of their…
Read More »Eli
hapabapa/iStock Editorial via Getty Images Sales from Eli Lilly’s (NYSE:LLY) newly approved weight loss medication, Zepbound, could reach $4.1B by…
Read More »It took some time, but Novo Nordisk may be facing the first real test of its dominance in the weight…
Read More »